NeoGenomics, Inc. (NEO)

NeoGenomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	164.12	367.01	342.49	263.18	316.83	228.71
Short-Term Investments	-	19.83	72.72	174.81	198.56	67.55
Cash & Short-Term Investments	164.12	386.84	415.2	437.99	515.39	296.26
Cash Growth	-57.68%	-6.83%	-5.20%	-15.02%	73.97%	71.23%
Receivables	155.8	150.64	131.26	121.61	113.87	108.49
Inventory	28.46	26.75	24.16	24.28	23.4	29.53
Prepaid Expenses	21.99	20.17	17.99	15.24	12.35	11.55
Other Current Assets	12.11	11.62	8.2	6.18	16.5	2.91
Total Current Assets	382.47	596.02	596.81	605.29	681.51	448.73
Property, Plant & Equipment	165.62	173.69	183.78	198.61	211.66	131.66
Long-Term Investments	-	-	-	-	-	29.56
Goodwill	524.34	522.77	522.77	522.77	527.12	211.08
Other Intangible Assets	294.16	339.68	373.13	408.26	442.33	120.65
Long-Term Accounts Receivable	-	-	-	0.03	0.24	0.29
Long-Term Deferred Charges	0.06	0.01	0.05	0.72	0.88	0.97
Other Long-Term Assets	8.13	5.88	4.69	4.36	6.05	45.39
Total Assets	1,375	1,638	1,681	1,740	1,870	988.33
Accounts Payable	22.61	21.61	20.33	20.51	17.92	24.97
Accrued Expenses	68.69	75.07	68.23	55.21	53.1	36.38
Current Portion of Long-Term Debt	-	200.78	-	0.07	1.14	2.84
Current Portion of Leases	4.51	3.38	5.61	6.58	6.88	4.97
Current Unearned Revenue	1.58	0.41	2.13	7.56	5.19	4.03
Other Current Liabilities	0.48	-	-	-	3	-
Total Current Liabilities	97.87	301.24	96.3	89.93	87.23	73.18
Long-Term Debt	341.48	340.34	538.2	535.32	532.48	169.09
Long-Term Leases	64.33	60.84	67.87	68.95	72.29	42.3
Long-Term Unearned Revenue	0.51	0.34	-	0.02	0.92	0.71
Long-Term Deferred Tax Liabilities	20.85	21.51	24.29	34.75	55.48	5.42
Other Long-Term Liabilities	11.47	11.44	13.03	13.04	13.11	3.34
Total Liabilities	536.49	735.7	739.69	742.01	761.5	294.04
Common Stock	0.13	0.13	0.13	0.13	0.12	0.11
Additional Paid-In Capital	1,262	1,228	1,190	1,161	1,124	701.36
Retained Earnings	-423.93	-325.78	-247.06	-159.09	-14.84	-7.19
Comprehensive Income & Other	0.07	-0.21	-1.67	-3.9	-0.64	0.01
Total Common Equity	838.29	902.34	941.54	998.02	1,108	694.29
Shareholders' Equity	838.29	902.34	941.54	998.02	1,108	694.29
Total Liabilities & Equity	1,375	1,638	1,681	1,740	1,870	988.33
Total Debt	410.31	605.33	611.68	610.93	612.79	219.19
Net Cash (Debt)	-246.19	-218.49	-196.48	-172.94	-97.4	77.07
Net Cash Growth	-	-	-	-	-	102.06%
Net Cash Per Share	-1.93	-1.73	-1.57	-1.39	-0.81	0.69
Filing Date Shares Outstanding	129.39	128.46	127.61	127.46	124.03	116.94
Total Common Shares Outstanding	128.89	128.15	127.37	126.91	124.11	112.08
Working Capital	284.6	294.78	500.51	515.36	594.28	375.55
Book Value Per Share	6.50	7.04	7.39	7.86	8.93	6.19
Tangible Book Value	19.78	39.89	45.64	67	138.84	362.56
Tangible Book Value Per Share	0.15	0.31	0.36	0.53	1.12	3.23
Land	-	-	-	-	-	3.17
Buildings	-	-	-	-	-	7.4
Machinery	-	147.43	142.03	136.88	127.95	103.5
Construction In Progress	-	8.51	3.61	8.98	12.4	6.29
Leasehold Improvements	-	57.57	49.23	44.42	43.25	27.69

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q